457 related articles for article (PubMed ID: 29800790)
1. Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke.
Tziomalos K; Sofogianni A; Angelopoulou SM; Christou K; Kostaki S; Papagianni M; Satsoglou S; Spanou M; Savopoulos C; Hatzitolios AI
Atherosclerosis; 2018 Jul; 274():206-211. PubMed ID: 29800790
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
[TBL] [Abstract][Full Text] [Related]
3. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of major lipids in patients with acute ischemic stroke.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
Metab Brain Dis; 2017 Apr; 32(2):395-400. PubMed ID: 27771869
[TBL] [Abstract][Full Text] [Related]
5. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
6. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
[TBL] [Abstract][Full Text] [Related]
7. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
8. Major Adipokines and the -420C>G Resistin Gene Polymorphism as Predictors of Acute Ischemic Stroke Severity and In-Hospital Outcome.
Bouziana SD; Tziomalos K; Goulas A; Vyzantiadis TA; Panderi A; Ηatzitolios AΙ
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):963-970. PubMed ID: 29217361
[TBL] [Abstract][Full Text] [Related]
9. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
[TBL] [Abstract][Full Text] [Related]
11. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
Yi S; Wang F; Wan M; Yi X; Zhang Y; Sun S
J Electrocardiol; 2020; 61():27-31. PubMed ID: 32504899
[TBL] [Abstract][Full Text] [Related]
12. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
Agarwal R; Light RP
Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
[TBL] [Abstract][Full Text] [Related]
13. Obesity and ECG left ventricular hypertrophy.
Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
[TBL] [Abstract][Full Text] [Related]
14. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
[TBL] [Abstract][Full Text] [Related]
17. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
[TBL] [Abstract][Full Text] [Related]
18. Increased augmentation index is paradoxically associated with lower in-hospital mortality in patients with acute ischemic stroke.
Tziomalos K; Bouziana SD; Spanou M; Giampatzis V; Papadopoulou M; Kazantzidou P; Kostaki S; Dourliou V; Savopoulos C; Hatzitolios AI
Atherosclerosis; 2014 Sep; 236(1):150-3. PubMed ID: 25046282
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of electrocardiographic left ventricular hypertrophy in the general population: A meta-analysis.
You Z; He T; Ding Y; Yang L; Jiang X; Huang L
J Electrocardiol; 2020; 62():14-19. PubMed ID: 32745730
[TBL] [Abstract][Full Text] [Related]
20. Impact of left ventricular hypertrophy on QT prolongation and associated mortality.
Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ
Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
